E Cannabis Central: Wall Street Analysts Recommend These 14 "Pot" Stocks

The fragmented and overcrowded marijuana industry makes it difficult for investors to know which pot stocks will stand the test of time so this article identifies the 14 pot stocks followed by Wall Street analysts according to money.cnn.com and details their buy/hold/sell recommendations for the 7 companies with market capitalizations of C$1B or more, share prices of C$5/share or more (i.e. non-penny) and covered by at least 10 analysts.

  1. Canopy Growth (NYSE:CGC) is followed by 25 analysts of which 10 recommend a Buy, 10 a Hold and 1 a Sell. On average, they forecast a 12-month stock price appreciation of 55%. At its current price of approximately US$22.85/share that equates to a projected price of US$35.40/share.
  2. Aurora Cannabis (NYSE:ACB) is followed by 18 analysts of which 9 recommend a Buy, 7 a Hold and 2 a Sell. On average, they forecast a 12-month stock price appreciation of 80%. At its current price of approximately US$4.40/share that equates to US$7.90/share.
  3. Tilray Inc. (Nasdaq:TLRY) is followed by 17 analysts of which 5 recommend a Buy, 11 a Hold and 1 a Sell. Their average 12-month forecast is an increase of 98% to its current price of US$26.50/share which equates to a 1-year price of US$52.50/share.
  4. Hexo Inc. (NYSE:HEXO) is followed by 15 analysts of which 11 recommend a Buy, 3 a Hold and 1 a Sell. Their average 12-month forecast is an increase of 94% to its current price of US$4/share which equates to a 1-year price of US$7.75/share.
  5. Cronos Group (Nasdaq:CRON) is followed by 15 analysts of which 4 recommend a Buy, 10 a Hold and 1 a Sell. Their average 12-month forecast is an increase of 57% to its current price of US$9/share which equates to US$14/share.
  6.  Aphria Inc. (NYSE:APHA) is followed by 11 analysts of which 8 recommend a Buy, 2 a Hold and 1 a Sell. Their average 12-month forecast is an increase of 93% to its current price of US$5.15/share which equates to US$9.95/share.
  7. Curaleaf Holdings (OTCQX:CURLF) is followed by 11 analysts of which 10 recommend a Buy and 1 a Hold. Their average 12-month forecast is an increase of 90% to its current price of US$5.40/share which equates to US$10.25/share.
1 2 3
View single page >> |
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Cannabis Stock Buyer 10 months ago Member's comment

Good summary but it doesn't say much else - what's your personal take on these stocks?